V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260014448 | 260009791 | 1.7 | 90.6 | Curative (C) | 2016-12-17 | 2016-12-17 | Cyclophosphamide High Dose | N | N | 260029606 | CHLORAMBUCIL |
| 260014449 | 260009791 | 1.79 | 85.1 | null | null | 2014-12-31 | BLEOMYCIN | null | null | 260029606 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014452 | 260009794 | 1.73 | 69 | Curative (C) | null | 2017-12-11 | DHAP | null | null | 260029620 | ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |
| 260014453 | 260009795 | 1.82 | 85 | Disease modification (D) | 2017-12-26 | 2018-01-01 | IMATINIB | 2 | N | 260029622 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014454 | 260009797 | 1.81 | 78.4 | Palliative (P) | 2017-07-10 | 2017-07-16 | STS Rhabdomyosarcoma RMS 2005 VA | N | N | 260029627 | VIP |
| 260014455 | 260009798 | null | 70.1 | Curative (C) | 2011-05-18 | 2013-10-18 | BLEOMYCIN + VINCRISTINE | N | N | 260029627 | CISPLATIN + GEMCITABINE + RITUXIMAB |
| 260014456 | 260009799 | null | null | Palliative (P) | 2015-10-17 | 2015-10-17 | Cytarabine HD + Methotrexate HD | N | N | 260029631 | NIVOLUMAB |
| 260014457 | 260009799 | 1.73 | 65 | Curative (C) | 2016-05-18 | 2016-05-25 | Pemetrexed | 02 | N | 260029631 | PEMETREXED |
| 260014458 | 260009800 | 1.75 | 48.1 | Disease modification (D) | 2013-08-31 | 2014-01-04 | BLEOMYCIN | N | null | 260029642 | ACE (GERM CELL) |
| 260014459 | 260009801 | null | 75.4 | Not known (9) | 2013-04-27 | 2013-05-04 | BLEOMYCIN | N | null | 260029642 | IVA |
| 260014460 | 260009804 | 1.69 | 47 | Disease modification (D) | 2015-12-22 | 2015-12-30 | BEAM + FLUDARABINE | N | N | 260029656 | DHAP - R |
| 260014461 | 260009804 | 1.68 | 76.7 | null | 2018-03-26 | 2018-04-24 | GEMCITABINE + TIP | N | null | 260029656 | IFOSFAMIDE + PACLITAXEL |
| 260014462 | 260009806 | null | 72.3 | Curative (C) | 2016-01-24 | 2016-02-29 | BOP | N | N | 260029660 | POMB/ACE |
| 260014463 | 260009809 | 1.66 | 79.5 | Curative (C) | 2016-09-06 | 2016-10-04 | ICE | N | N | 260029660 | DOCETAXEL + TRASTUZUMAB |
| 260014464 | 260009810 | 1.63 | 64.4 | Curative (C) | 2016-10-12 | 2016-10-20 | ICE | 02 | null | 260029663 | CARBOPLATIN + PACLITAXEL |
| 260014465 | 260009813 | 1.73 | 51.6 | Curative (C) | 2016-05-03 | 2016-05-09 | ICE | N | N | 260029667 | TRASTUZUMAB |
| 260014466 | 260009813 | 1.61 | 72 | Curative (C) | 2012-11-16 | 2012-11-17 | BLEOMYCIN + VINCRISTINE | 02 | N | 260029667 | CHOP |
| 260014467 | 260014666 | 1.6 | 66.3 | Adjuvant (A) | 2017-03-19 | 2017-03-21 | CVP | N | N | 260029688 | CISPLATIN |
| 260014468 | 260014667 | 1.61 | 80.6 | null | 2017-01-05 | 2017-01-05 | Carboplatin + Etoposide iv&po | 2 | N | 260029692 | CARBOPLATIN + EPIRUBICIN + ETOPOSIDE + MELPHALAN |
| 260014469 | 260017032 | 1.63 | 94.3 | Disease modification (D) | 2015-03-11 | 2015-03-23 | DHAP - R | 2 | N | 260029694 | CYCLOPHOSPHAMIDE |
| 260014470 | 260009819 | 1.73 | 71.2 | Palliative (P) | 2015-06-12 | 2015-06-20 | CYCLOPHOSPHAMIDE | N | N | 260029695 | CARBOPLATIN + THIOTEPA + TOPOTECAN |
| 260014471 | 260009821 | 0 | 77.7 | Curative (C) | 2018-10-23 | 2019-02-01 | Cisplatin 7 day | N | N | 260029697 | ICE |
| 260014472 | 260009821 | 1.55 | 101 | Curative (C) | 2016-07-10 | 2016-07-10 | Docetaxel | 2 | N | 260029697 | CISPLATIN + VINORELBINE + RT |
| 260014473 | 260009821 | 1.71 | 103 | Curative (C) | 2017-05-24 | 2017-05-29 | IFOSFAMIDE + PACLITAXEL | 02 | N | 260029697 | CYCLOPHOSPHAMIDE |
| 260014474 | 260009822 | 1.8 | 65.3 | Palliative (P) | 2017-01-29 | 2017-02-20 | BLEOMYCIN + CISPLATIN + VINCRISTINE | N | N | 260029713 | CISPLATIN + ETOPOSIDE + PACLITAXEL |
| 260014475 | 260009824 | 1.74 | 74.8 | Curative (C) | 2016-04-18 | 2016-04-18 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE | N | N | 260029713 | GEMCITABINE + TIP |
| 260014476 | 260009827 | 1.64 | 74 | Curative (C) | 2013-07-22 | 2013-07-26 | IVA | 2 | N | 260029720 | CARBOPLATIN + IFOSFAMIDE + PACLITAXEL |
| 260014477 | 260009828 | 1.82 | 68.8 | Palliative (P) | 2016-06-24 | 2016-06-24 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 260029725 | CARBOPLATIN + ETOPOSIDE |
| 260014478 | 260014672 | 1.67 | 94.1 | Disease modification (D) | 2017-02-14 | 2017-03-23 | Docetaxel + Trastuzumab (Maint) | N | N | 260029725 | CARBOPLATIN + PACLITAXEL |
| 260014479 | 260009832 | 1.73 | 82 | Curative (C) | 2013-11-30 | 2013-12-01 | METHOTREXATE | N | N | 260029745 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014480 | 260014673 | 1.64 | 72 | Palliative (P) | 2013-11-02 | 2013-12-20 | ICE | N | N | 260029746 | ICE |
| 260014481 | 260009836 | 1.82 | 65 | Curative (C) | 2015-06-20 | 2015-06-20 | CARBOPLATIN + ETOPOSIDE | 02 | N | 260029747 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260014482 | 260009836 | 1.75 | 50.8 | Curative (C) | 2018-02-25 | 2018-02-27 | Cyclophosphamide High Dose | 02 | N | 260029747 | TRASTUZUMAB |
| 260014483 | 260009836 | 1.69 | 90.5 | null | 2018-06-25 | 2018-06-25 | ICE + GCSF | 02 | N | 260029747 | MAP |
| 260014484 | 260009838 | 1.77 | 65.3 | null | 2018-03-06 | 2018-04-06 | VeIP | N | N | 260029759 | VIP |
| 260014485 | 260009839 | null | null | Disease modification (D) | 2013-04-04 | 2013-04-11 | Methotrexate + Folinic acid | N | N | 260029759 | IVA |
| 260014486 | 260009839 | 1.73 | 67.5 | Curative (C) | 2018-10-31 | 2018-10-31 | TRASTUZUMAB | 02 | N | 260029759 | TRASTUZUMAB |
| 260014487 | 260014677 | 1.56 | 74.7 | Curative (C) | 2018-02-20 | 2018-02-20 | Cisplatin 7 day | N | N | 260029769 | CVP |
| 260014488 | 260009841 | 1.58 | 76 | Adjuvant (A) | 2015-05-09 | 2015-05-10 | TRASTUZUMAB | 2 | N | 260029776 | NIVOLUMAB |
| 260014489 | 260009841 | 1.75 | 76.5 | Palliative (P) | 2013-03-27 | 2013-03-27 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 260029776 | BLEOMYCIN |
| 260014490 | 260009842 | null | null | null | 2017-10-13 | 2017-10-13 | CVP | N | N | 260029793 | TRASTUZUMAB |
| 260014491 | 260009842 | 1.63 | null | Disease modification (D) | 2015-12-11 | 2016-02-14 | IBRUTINIB | 02 | null | 260029793 | IBRUTINIB |
| 260014492 | 260009843 | 1.81 | null | Curative (C) | 2017-11-10 | 2017-11-10 | IFOSFAMIDE + PACLITAXEL | N | null | 260029805 | OBINUTUZUMAB |
| 260014493 | 260014680 | 1.79 | 100 | Curative (C) | 2016-12-14 | 2016-12-18 | Paclitaxel Priming | 02 | N | 260029816 | CARBOPLATIN + ETOPOSIDE |
| 260014494 | 260014680 | 1.69 | 77 | Disease modification (D) | 2016-10-08 | 2016-10-26 | Docetaxel | 02 | N | 260029816 | CARBOPLATIN + ETOPOSIDE |
| 260014495 | 260009845 | 1.5 | 94.1 | Disease modification (D) | 2015-02-13 | 2015-02-16 | DOCETAXEL + TRASTUZUMAB | 02 | N | 260029822 | NIVOLUMAB |
| 260014496 | 260017040 | 1.88 | 100.2 | Adjuvant (A) | 2018-04-23 | 2018-04-23 | BLEOMYCIN + CISPLATIN + ETOPOSIDE + PACLITAXEL | 02 | N | 260029823 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260014497 | 260017040 | 1.74 | 105 | Palliative (P) | 2015-03-17 | 2015-03-28 | IFOSFAMIDE + PACLITAXEL | N | N | 260029823 | BLEOMYCIN + CISPLATIN + ETOPOSIDE |
| 260014498 | 260009847 | 1.63 | 60 | Curative (C) | 2015-08-16 | 2015-08-25 | NIVOLUMAB | N | N | 260029854 | CISPLATIN + VINORELBINE + RT |
| 260014499 | 260009847 | 1.76 | 73.8 | Palliative (P) | 2014-12-19 | 2014-12-19 | Carboplatin + Etoposide IV 3 day | 02 | N | 260029854 | EP |